NCT06709547 Mortality Prediction Using Trauma Scores
| NCT ID | NCT06709547 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Al-Nahrain University |
| Condition | Trauma, Multiple |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2025-01-28 |
| Primary Completion | 2025-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2025-01-28 with a primary completion date of 2025-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective cohort study is to compare the predictive utility of the Injury Severity Score (ISS), New Injury Severity Score (NISS), Revised Trauma Score (RTS), and Trauma and Injury Severity Score (TRISS) in determining mortality outcomes among trauma patients admitted to the trauma and emergency department at Kadhimiya Educational Hospital in Baghdad. The main questions it aims to answer are: Which trauma scoring system provides the most accurate prediction of mortality? Are there specific trauma patient subgroups where one scoring system outperforms the others? Participants will: Be assessed using all four trauma scoring systems (ISS, NISS, RTS, and TRISS) upon admission to the trauma and emergency department. Have their clinical outcomes, including mortality, length of hospital stay, ICU admission, and discharge status, monitored throughout their hospital stay to evaluate the accuracy and utility of each scoring system in predicting patient outcomes.
Eligibility Criteria
Inclusion Criteria: * Trauma patients admitted to the emergency room (ER). * Documented injury data sufficient to calculate both the New Injury Severity Score (NISS) and the Injury Severity Score (ISS). * Trauma scores (ISS, NISS, Revised Trauma Score \[RTS\], and Trauma and Injury Severity Score \[TRISS\]) calculated within 12 hour of arrival to ensure timely predictions. * Informed consent provided by the patient or a legal guardian in cases of incapacity. Exclusion Criteria: * Under 18 years of age and pregnant women, due to differences in trauma management and scoring applicability. * Non-trauma cases, including patients with terminal illnesses or severe cognitive impairments, to maintain focus on trauma outcomes. * Incomplete trauma scoring, missing or incomplete medical records, and * patients not treated in the trauma or emergency department. * Patients who refuse participation or withdraw consent to ensure ethical participation. * Transferred patients and those enrolled in other research studies that could interfere with trauma scoring.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06709547 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Trauma, Multiple. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06709547 currently recruiting?
Yes, NCT06709547 is actively recruiting participants. Contact the research team at allaabed987@ced.nahrainuniv.edu.iq for enrollment information.
Where is the NCT06709547 trial being conducted?
This trial is being conducted at Baghdad, Iraq.
Who is sponsoring the NCT06709547 clinical trial?
NCT06709547 is sponsored by Al-Nahrain University. The trial plans to enroll 150 participants.